Osmotica Pharmaceutical Corp is recalling 19,664 bottles of Trigen Laboratories Methylphenidate Hydrochloride Extended-release (ER) Tablets, USP, 36 mg. This recall was initiated because some 100-count bottles labeled as 36 mg tablets were found to contain a single 27 mg tablet instead. This means patients may receive a lower dose of medication than prescribed. Consumers should contact their healthcare provider or pharmacist regarding this medication.
A patient unknowingly taking a 27 mg tablet instead of the prescribed 36 mg dose will receive a lower amount of medication than intended. This subpotent dosing may lead to a temporary reduction in the effectiveness of the treatment for their condition.
Healthcare consultation and pharmacy refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.